Stocks · Health care · Biological Products, (No Diagnostic Substances)

Metagenomi Therapeutics, Inc.

MGX Clue Score24

United States Fiscal year ends December CIK 0001785279 Results filed 10 Aug 2026

Add to watchlist

By person

6 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Laurence Reid

Director

$23.40K (2)

—

+$23.40K

20,000

0.0529%

$23.60K

—

Jian Irish

See Remarks

—

$12.74K (4)

−$12.74K

668,106

1.77%

$788.37K

+12.1%

Pamela Wapnick

Chief Financial Officer

—

$11.28K (4)

−$11.28K

206,580

0.5468%

$243.76K

+227.6%

Brian C. Thomas

Director

—

$6.79K (1)

−$6.79K

2,510,960

6.65%

$2.96M

+0.6%

Matthew Wein

See Remarks

—

$2.26K (4)

−$2.26K

126,133

0.3339%

$148.84K

+762.0%

Sarah B. Noonberg

Chief Medical Officer

—

109,135

0.2889%

$128.78K

+8.7%

Metagenomi Therapeutics, Inc.

What the insiders did Net selling

By person